Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.12 (
PKG
)
2,515
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In collecting duct principal cells,
aquaporin 2
(
AQP2
) is shuttled from intracellular vesicles to the plasma membrane upon vasopressin (VP) stimulation. VP activates adenylyl cyclase, increases intracellular cAMP, activating protein kinase A (PKA) to phosphorylate
AQP2
on the COOH-terminal residue, serine 256. Using rat kidney slices and LLC-PK1 cells stably expressing
AQP2
(LLC-
AQP2
cells), we now show that
AQP2
trafficking can be stimulated by cAMP-independent pathways. In these systems, the nitric oxide (NO) donors sodium nitroprusside (SNP) and NONOate and the NO synthase substrate L-arginine mimicked the effect of VP, stimulating relocation of
AQP2
from cytoplasmic vesicles to the plasma membrane. Unlike VP, these other agents did not increase intracellular cAMP. However, SNP increased intracellular cGMP, and exogenous cGMP stimulated
AQP2
-membrane insertion. Atrial natriuretic factor, which signals via cGMP, also stimulated
AQP2
translocation. The VP and SNP effects were blocked by the kinase inhibitor H89. SNP did not stimulate membrane insertion of
AQP2
in LLC-PK1 cells expressing the phosphorylation-deficient mutant 256SerAla-
AQP2
, indicating that phosphorylation of Ser256 is required for signaling. Both PKA and
cGMP-dependent protein kinase
G phosphorylated
AQP2
on this COOH-terminal residue in vitro. These results demonstrate a novel, cAMP-independent and cGMP-dependent pathway for
AQP2
membrane insertion in renal epithelial cells.
...
PMID:Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells. 1106 64